FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.

Read more: https://www.curetoday.com/view/fda-grants-rare-pediatric-designation-to-treatment-with-neo100-in-brain-cancer